---
title: "Cellebrite beats top-line estimates; initiates Q1 and FY25 outlook"
date: "2025-02-13 15:20:20"
summary: "Cellebrite press release (NASDAQ:CLBT): Q4 Non-GAAP EPS of $0.10 in-line. Revenue of $109M (+17.2% Y/Y) beats by $1.86M. ARR grew 25% to $395.9 million. Fourth-quarter 2024 adjusted EBITDA of $28.8 million, 26.4% adjusted EBITDA margin. Subscription revenue was $95.1 million, up 21% year-over-year. Annual Recurring Revenue of $395.9 million, up..."
categories:
  - "seekalpha"
lang:
  - "en"
translations:
  - "en"
tags:
  - "seekalpha"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

* Cellebrite [press release](https://seekingalpha.com/pr/20001234-cellebrite-announces-fourth-quarter-and-full-year-2024-results) (NASDAQ:[CLBT](https://seekingalpha.com/symbol/CLBT "Cellebrite DI Ltd.")): Q4 Non-GAAP EPS of $0.10 in-line.
* Revenue of $109M (+17.2% Y/Y)  beats by $1.86M.
* *ARR grew 25% to $395.9 million.*
* *Fourth-quarter 2024 adjusted EBITDA of $28.8 million, 26.4% adjusted EBITDA margin.*
* Subscription revenue was $95.1 million, up 21% year-over-year.
* Annual Recurring Revenue of $395.9 million, up 25% year-over-year.
* Recurring revenue dollar-based net retention rate of 124%.
* **The Companyâ€™s first-quarter and full-year expectations for 2025 are as follows:**
  
   
  
  |  |  | First-Quarter 2025 Expectations(as of 2/13/25) |  | Full-Year 2025 Expectations(as of 2/13/25) |
  | --- | --- | --- | --- | --- |
  | ARR |  | $406 million - $411 million |  | $480 million - $495 million |
  | Annual growth |  | 22% - 24% |  | 21% - 25% |
  | Revenue |  | $107 million - $112 million **vs. $105.54M consensus** |  | $480 million - $490 million **vs. $465.57M consensus** |
  | Annual growth |  | 19% - 25% |  | 20% - 22% |
  | Adjusted EBITDA |  | $22 million - $24 million |  | $113 million - $123 million |
  | Adjusted EBITDA margin |  | ~21% |  | 24% - 25% |

[seekalpha](https://seekingalpha.com/news/4407597-cellebrite-beats-top-line-estimates-initiates-q1-and-fy25-outlook)
